Transatrial lead implantation using the 4-Fr lumenless pacing lead and delivery system in young adults with congenital heart disease.
We report the technique of transatrial delivery of the Medtronic 3830 SelectSecure lead (Medtronic Inc., Minneapolis, MN, USA) for right ventricular endocardial pacing in two young adults with congenital heart disease who had multiple pacing lead failures and superior vena cava occlusion. The deflectable catheter delivery system used to position the SelectSecure lead provided the opportunity to map the right ventricular endocardial surface and determine the best available pacing site. At midterm follow-up, both systems are functioning well.